City

Comayagua (1)

Djibouti (1)

Nanyuki (1)

New York (1)

Condition

Diarrhea Travelers (2)

Antibiotic Resistant Infection (1)

Diarrhoea;Acute (1)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 3 (1)

phase 4 (1)

Sponsor

Centers for Disease Control and Prevention (1)

Henry M. Jackson Foundation for the Advancement of Military Medicine (1)

Collaborator

Infectious Diseases Clinical Research Program (1)

Procter and Gamble (1)

The New York Center for Travel and Tropical Medicine (1)

Uniformed Services University of the Health Sciences (1)

Intervention

azithromycin 500 mg (1)

bismuth subsalicylate (1)

loperamide (1)

placebo oral tablet (1)

rifaximin 550 mg (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (1)

U.S. Fed (1)

Study Type

Interventional (2)

diarrhea travelers

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Diarrhoea;Acute, Diarrhea Travelers Trial in Djibouti, Comayagua, Nanyuki (Rifaximin 550 MG, Azithromycin 500 MG, Loperamide)

Recruiting

Diarrhoea;Acute
Diarrhea Travelers

Rifaximin 550 MG
+2 more

Djibouti, Djibouti
+2 more

Jan 9, 2023

Diarrhea Travelers, Antibiotic Resistant Infection Trial in New York (Bismuth subsalicylate, Placebo Oral Tablet)

Recruiting

Diarrhea Travelers
Antibiotic Resistant Infection

Bismuth subsalicylate
Placebo Oral Tablet

New York, New York

Jefferson Garcia

Feb 24, 2022